Skip to Content

Cancers, Volume 14, Issue 17

2022 September-1 - 280 articles

Cover Story: Multiple myeloma (MM) is a complex hematologic malignancy caused by the uncontrolled expansion of clonal plasma cells. In recent days, several mechanism-driven therapeutics have entered the routine clinical practice, offering a significant survival benefit and improved quality of life. The current treatment paradigm includes advanced plasma-directed therapies, such as new generation of proteasome inhibitors and immunomodulators, targeted therapies, immunotherapies, and most recently engineered T-cell therapies. Despite these advancements, mortality remains high, with most patients becoming resistant/refractory to available therapeutics, emphasizing the urgent need for new strategies. A deeper insight into the genetic and epigenetic basis of the molecular evolution from precursor states to MM will help us to develop newer therapeutic strategies to combat this incurable disease. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (280)

  • Article
  • Open Access
21 Citations
7,050 Views
13 Pages

Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study

  • Kuo-Chang Wen,
  • Rui-Lan Huang,
  • Lin-Yu Chen,
  • Tzu-I Wu and ,
  • Chien-Hsing Lu,
  • Tang-Yuan Chu,
  • Yu-Che Ou,
  • Chen-Hsuan Wu,
  • Shih-Tien Hsu and
  • Hung-Cheng Lai
  • + 14 authors+ 9 authors

5 September 2022

Background: We describe a DNA methylation assay, named MPap test, using cervical scraping as an alternative technique for endometrial cancer detection. Methods: A multicenter hospital-based, two-stage validation study was conducted to validate the ca...

  • Article
  • Open Access
29 Citations
3,937 Views
10 Pages

Multi-Class Cancer Subtyping in Salivary Gland Carcinomas with MALDI Imaging and Deep Learning

  • David Pertzborn,
  • Christoph Arolt,
  • Günther Ernst,
  • Oliver J. Lechtenfeld and ,
  • Jan Kaesler,
  • Daniela Pelzel,
  • Orlando Guntinas-Lichius,
  • Ferdinand von Eggeling and
  • Franziska Hoffmann
  • + 4 authors+ 0 author

5 September 2022

Salivary gland carcinomas (SGC) are a heterogeneous group of tumors. The prognosis varies strongly according to its type, and even the distinction between benign and malign tumor is challenging. Adenoid cystic carcinoma (AdCy) is one subgroup of SGCs...

(This article belongs to the Special Issue Salivary Gland Adenoid Cystic Carcinoma)
  • Review
  • Open Access
46 Citations
7,008 Views
16 Pages

Electrochemotherapy: An Alternative Strategy for Improving Therapy in Drug-Resistant SOLID Tumors

  • Maria Condello,
  • Gloria D’Avack,
  • Enrico Pierluigi Spugnini and
  • Stefania Meschini

5 September 2022

Electrochemotherapy (ECT) is one of the innovative strategies to overcome the multi drug resistance (MDR) that often occurs in cancer. Resistance to anticancer drugs results from a variety of factors, such as genetic or epigenetic changes, an up-regu...

(This article belongs to the Collection Drug Resistance and Novel Therapies in Cancers)
  • Article
  • Open Access
8 Citations
3,732 Views
15 Pages

Impact of Preoperative Chemotherapy Features on Patient Outcomes after Hepatectomy for Initially Unresectable Colorectal Cancer Liver Metastases: A LiverMetSurvey Analysis

  • Pasquale F. Innominato,
  • Valérie Cailliez,
  • Marc-Antoine Allard,
  • Santiago Lopez-Ben and ,
  • Alessandro Ferrero,
  • Hugo Marques,
  • Catherine Hubert,
  • Felice Giuliante,
  • Fernando Pereira and
  • René Adam
  • + 23 authors+ 18 authors

5 September 2022

Background: Prognostic factors have been extensively reported after resection of colorectal liver metastases (CLM); however, specific analyses of the impact of preoperative systemic anticancer therapy (PO-SACT) features on outcomes is lacking. Method...

(This article belongs to the Special Issue Prognostic and Therapeutic Implications of Tumor Biology in Colorectal Liver Metastases)
  • Article
  • Open Access
5 Citations
3,599 Views
14 Pages

5 September 2022

Therapeutic vaccine studies should be designed to elicit durable, high magnitude, and efficacious T cell responses, all of which can be impacted by the choice of the vaccination schedule. Here, we compare different prime-boost intervals (PBI) in a hu...

(This article belongs to the Special Issue Advances in Immuno-Oncology Research)
  • Article
  • Open Access
16 Citations
3,697 Views
11 Pages

Impact of COVID-19 Pandemic on Thyroid Surgery in a University Hospital in South Korea

  • Seong Hoon Kim,
  • Euna Min,
  • Young Mi Hwang,
  • Yun Suk Choi and
  • Jin Wook Yi

5 September 2022

The COVID-19 pandemic has changed healthcare systems around the world. Medical personnel concentrated on infectious disease management and treatments for non-emergency diseases and scheduled surgeries were delayed. We aimed to investigate the change...

(This article belongs to the Special Issue Coronavirus Disease (COVID-19) and Its Impact on Patients with Cancer)
  • Article
  • Open Access
17 Citations
3,005 Views
12 Pages

A Score to Predict the Malignancy of a Breast Lesion Based on Different Contrast Enhancement Patterns in Contrast-Enhanced Spectral Mammography

  • Luca Nicosia,
  • Anna Carla Bozzini,
  • Simone Palma,
  • Marta Montesano and ,
  • Filippo Pesapane,
  • Federica Ferrari,
  • Valeria Dominelli,
  • Anna Rotili,
  • Lorenza Meneghetti and
  • Enrico Cassano
  • + 8 authors+ 3 authors

5 September 2022

Background: To create a predictive score of malignancy of a breast lesion based on the main contrast enhancement features ascertained by contrast-enhanced spectral mammography (CESM). Methods: In this single-centre prospective study, patients with su...

  • Article
  • Open Access
31 Citations
6,613 Views
21 Pages

Interleukin 4 Controls the Pro-Tumoral Role of Macrophages in Mammary Cancer Pulmonary Metastasis in Mice

  • Carolina Rodriguez-Tirado,
  • David Entenberg,
  • Jiufeng Li,
  • Bin-Zhi Qian and ,
  • John S. Condeelis and
  • Jeffrey W. Pollard
  • + 1 author+ 0 author

5 September 2022

Metastasis is the systemic manifestation of cancer and the main cause of death from breast cancer. In mouse models of lung metastases, recruitment of classical monocytes from blood to the lung and their differentiation to metastasis-associated macrop...

  • Article
  • Open Access
4 Citations
5,514 Views
13 Pages

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

  • Michael J. Wagner,
  • Cassandra Hennessy,
  • Alicia Beeghly,
  • Benjamin French and ,
  • Dimpy P. Shah,
  • Sarah Croessmann,
  • Diana Vilar-Compte,
  • Erika Ruiz-Garcia,
  • Matthew Ingham and
  • Elizabeth J. Davis
  • + 42 authors+ 37 authors

5 September 2022

Background: Patients with sarcoma often require individualized treatment strategies and are likely to receive aggressive immunosuppressive therapies, which may place them at higher risk for severe COVID-19. We aimed to describe demographics, risk fac...

  • Article
  • Open Access
27 Citations
5,555 Views
15 Pages

The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study

  • Mingying Xie,
  • Na Li,
  • Xiaoling Xu,
  • Yanjun Xu and ,
  • Hui Li,
  • Liang Zhu,
  • Jiamin Sheng,
  • Zichao Zhou and
  • Yun Fan
  • + 4 authors+ 0 author

5 September 2022

Background: A controversy exists regarding the efficacy of programmed death-1 (PD-1)/ programmed death ligand-1 (PD-L1) inhibitors for patients with non-small cell lung cancer (NSCLC) and liver metastases. Our study retrospectively evaluated the effi...

(This article belongs to the Special Issue Advances in Lung Cancer Therapy)
  • Review
  • Open Access
43 Citations
8,236 Views
18 Pages

PARP Inhibitors for Breast Cancer: Germline BRCA1/2 and Beyond

  • Maria Clara Saad Menezes,
  • Farah Raheem,
  • Lida Mina,
  • Brenda Ernst and
  • Felipe Batalini

5 September 2022

Poly-adenosine diphosphate ribose polymerase (PARP) inhibitors (PARPi) are approved for BRCA1/2 carriers with HER2-negative breast cancer in the adjuvant setting with a high risk of recurrence as well as the metastatic setting. However, the indicatio...

(This article belongs to the Special Issue Genomic Landscape of Breast Cancer: From Primary to Metastasis)
  • Article
  • Open Access
18 Citations
5,328 Views
13 Pages

Comparing Apparent Diffusion Coefficient and FNCLCC Grading to Improve Pretreatment Grading of Soft Tissue Sarcoma—A Translational Feasibility Study on Fusion Imaging

  • Madelaine Hettler,
  • Julia Kitz,
  • Ali Seif Amir Hosseini,
  • Manuel Guhlich and ,
  • Babak Panahi,
  • Jennifer Ernst,
  • Lena-Christin Conradi,
  • Michael Ghadimi,
  • Philipp Ströbel and
  • Jens Jakob
  • + 5 authors+ 0 author

5 September 2022

Histological subtype and grading are cornerstones of treatment decisions in soft tissue sarcoma (STS). Due to intratumoral heterogeneity, pretreatment grading assessment is frequently unreliable and may be improved through functional imaging. In this...

  • Review
  • Open Access
8 Citations
4,641 Views
17 Pages

5 September 2022

The COVID-19 pandemic accounts for more than 500 million confirmed infections and over 6 million deaths worldwide in the last 2 years. SARS-CoV-2 causes a highly complex form of inflammation that affects the human organism both acutely and chronicall...

  • Article
  • Open Access
6 Citations
3,234 Views
15 Pages

4 September 2022

Accurate demographic data are critical for comprehending and treating cutaneous T-cell lymphoma (CTCL). Our research aimed to determine the demographics and incidence trends of CTCL patients in Arkansas compared to those of the national CTCL populati...

(This article belongs to the Special Issue Population-Based Research on Modifiable Risk Factors for Cancer)
  • Systematic Review
  • Open Access
26 Citations
4,521 Views
15 Pages

Neoadjuvant Stereotactic Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis of the Literature and Ongoing Clinical Trials

  • Paolo Palmisciano,
  • Gianluca Ferini,
  • Ramlah Khan,
  • Othman Bin-Alamer and ,
  • Giuseppe E. Umana,
  • Kenny Yu,
  • Aaron A. Cohen-Gadol,
  • Tarek Y. El Ahmadieh and
  • Ali S. Haider
  • + 4 authors+ 0 author

4 September 2022

Background: Brain metastases (BMs) carry a high morbidity and mortality burden. Neoadjuvant stereotactic radiotherapy (NaSRT) has shown promising results. We systematically reviewed the literature on NaSRT for BMs. Methods: PubMed, EMBASE, Scopus, We...

(This article belongs to the Special Issue Advances in Stereotactic Radiotherapy of Brain Metastases)
  • Editorial
  • Open Access
3 Citations
2,877 Views
3 Pages

4 September 2022

We are proud and happy to present this Special Issue, a follow-up to the third joint meeting on lung cancer of the FHU OncoAge (University Côte d’Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA)...

(This article belongs to the Special Issue Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients. A Selection of Papers from the Third Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA))
  • Article
  • Open Access
10 Citations
5,102 Views
13 Pages

Clone Phylogenetics Reveals Metastatic Tumor Migrations, Maps, and Models

  • Antonia Chroni,
  • Sayaka Miura,
  • Lauren Hamilton,
  • Tracy Vu and ,
  • Stephen G. Gaffney,
  • Vivian Aly,
  • Sajjad Karim,
  • Maxwell Sanderford,
  • Jeffrey P. Townsend and
  • Sudhir Kumar
  • + 5 authors+ 0 author

4 September 2022

Dispersal routes of metastatic cells are not medically detected or even visible. A molecular evolutionary analysis of tumor variation provides a way to retrospectively infer metastatic migration histories and answer questions such as whether the majo...

(This article belongs to the Special Issue Advance in Computational Methods in Cancer Research)
  • Article
  • Open Access
4 Citations
3,235 Views
15 Pages

Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers

  • Yuquan Qian,
  • Timo Itzel,
  • Matthias Ebert and
  • Andreas Teufel

3 September 2022

Background: Gene expression signatures correlate genetic alterations with specific clinical features, providing the potential for clinical usage. A plethora of HCC-dependent gene signatures have been developed in the last two decades. However, none o...

  • Systematic Review
  • Open Access
20 Citations
7,560 Views
21 Pages

Guidelines for Cancer Treatment during Pregnancy: Ethics-Related Content Evolution and Implications for Clinicians

  • Alma Linkeviciute,
  • Rita Canario,
  • Fedro Alessandro Peccatori and
  • Kris Dierickx

3 September 2022

(1) Background: Current scientific evidence suggests that most cancers, including breast cancer, can be treated during pregnancy without compromising maternal and fetal outcomes. This, however, raises questions regarding the ethical implications of c...

(This article belongs to the Special Issue Breast Cancer: Clinical Trial and Translational Research)
  • Review
  • Open Access
21 Citations
6,724 Views
14 Pages

An Overview of Pituitary Incidentalomas: Diagnosis, Clinical Features, and Management

  • Shigeyuki Tahara,
  • Yujiro Hattori,
  • Koji Suzuki,
  • Eitaro Ishisaka and ,
  • Shinichiro Teramoto and
  • Akio Morita
  • + 1 author+ 0 author

3 September 2022

Pituitary incidentalomas are tumors or mass lesions of the pituitary gland. These are incidentally discovered during imaging studies for symptoms that are not causally related to pituitary diseases. The most common symptom that triggers an examinatio...

(This article belongs to the Special Issue Pituitary Tumors: Molecular Insights, Diagnosis, and Targeted Therapy)
  • Article
  • Open Access
6 Citations
2,895 Views
10 Pages

Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer

  • Chan Su Park,
  • Min Je Sung,
  • So Jeong Kim,
  • Jung Hyun Jo and ,
  • Hee Seung Lee,
  • Moon Jae Chung,
  • Seungmin Bang,
  • Seung Woo Park,
  • Si Young Song and
  • Jeong Youp Park
  • + 5 authors+ 0 author

3 September 2022

Some BTC types respond to pembrolizumab, but there are no known prognostic factors to predict its treatment benefits. In this study, we attempted to identify the prognostic factors associated with pembrolizumab as a second-line treatment for gemcitab...

  • Article
  • Open Access
32 Citations
6,555 Views
20 Pages

The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma

  • Imogen Sharkey Ochoa,
  • Esther O’Regan,
  • Mary Toner,
  • Elaine Kay and ,
  • Peter Faul,
  • Connor O’Keane,
  • Roisin O’Connor,
  • Dorinda Mullen,
  • Mataz Nur and
  • Cara M. Martin
  • + 18 authors+ 13 authors

3 September 2022

Human papillomavirus (HPV) infection has been identified as a significant etiological agent in the development of head and neck squamous cell carcinoma (HNSCC). HPV’s involvement has alluded to better survival and prognosis in patients and sugg...

  • Article
  • Open Access
13 Citations
3,254 Views
15 Pages

Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade

  • Rebecca Marcus,
  • Wade Christopher,
  • Jennifer Keller,
  • Sean Nassoiy and ,
  • Shu-Ching Chang,
  • Melanie Goldfarb,
  • Ronald Wolf and
  • Zeljka Jutric
  • + 3 authors+ 0 author

3 September 2022

Limited evidence-based management guidelines for resectable intrahepatic cholangiocarcinoma (ICC) currently exist. Using a large population-based cancer registry; the utilization rates and outcomes for patients with clinical stages I-III ICC treated...

(This article belongs to the Special Issue Translational Research of Liver Cancer)
  • Article
  • Open Access
6 Citations
2,984 Views
9 Pages

3 September 2022

In cases of progression despite chemotherapy, collecting gastric cancer (GC) tissues might be helpful for molecular biology research or the development of new target drugs for treating cases that are refractory to chemotherapy. Chemotherapy, however,...

  • Review
  • Open Access
55 Citations
10,609 Views
24 Pages

Current Progress of CAR-NK Therapy in Cancer Treatment

  • Zhaojun Pang,
  • Zhongyi Wang,
  • Fengqi Li,
  • Chunjing Feng and
  • Xin Mu

2 September 2022

CD8+ T cells and natural killer (NK) cells eliminate target cells through the release of lytic granules and Fas ligand (FasL)-induced target cell apoptosis. The introduction of chimeric antigen receptor (CAR) makes these two types of cells selective...

(This article belongs to the Special Issue Cancer Immunotherapy and Immune-Related Adverse Events)
  • Article
  • Open Access
3 Citations
2,624 Views
11 Pages

Differences in Stakeholders’ Perception of the Impact of COVID-19 on Clinical Care and Decision-Making

  • Joerg Haier,
  • Johannes Beller,
  • Kristina Adorjan,
  • Stefan Bleich and ,
  • Moritz de Greck,
  • Frank Griesinger,
  • Markus V. Heppt,
  • René Hurlemann,
  • Soeren Torge Mees and
  • Juergen Schaefers
  • + 11 authors+ 6 authors

2 September 2022

Background: Pandemics are related to changes in clinical management. Factors that are associated with individual perceptions of related risks and decision-making processes focused on prevention and vaccination, but perceptions of other healthcare con...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Article
  • Open Access
13 Citations
4,101 Views
20 Pages

Nrf2 Downregulation Contributes to Epithelial-to-Mesenchymal Transition in Helicobacter pylori-Infected Cells

  • Sarah Bacon,
  • Lornella Seeneevassen,
  • Alison Fratacci,
  • Faustine Rose and ,
  • Camille Tiffon,
  • Elodie Sifré,
  • Maria M. Haykal,
  • Maya M. Moubarak,
  • Astrid Ducournau and
  • Océane C. B. Martin
  • + 13 authors+ 8 authors

2 September 2022

Background: Gastric cancer, the fifth most common cancer worldwide, is mainly linked to Helicobacter pylori infection. H. pylori induces chronic inflammation of the gastric mucosa associated with high oxidative stress. Our study aimed at assessing th...

(This article belongs to the Special Issue New Molecular Insights for GC Characterization and Treatment)
  • Review
  • Open Access
35 Citations
8,934 Views
27 Pages

Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure

  • Debora Capelli,
  • Diego Menotti,
  • Alessandro Fiorentini,
  • Francesco Saraceni and
  • Attilio Olivieri

2 September 2022

FLT3 ITD and TKD mutations occur in 20% and 10% of Acute Myeloid Leukemia (AML), respectively, and they represent the target of the first approved anti-leukemic therapies in the 2000s. Type I and type II FLT3 inhibitors (FLT3i) are active against FLT...

(This article belongs to the Collection Acute Myeloid Leukemia (AML))
  • Review
  • Open Access
39 Citations
10,680 Views
13 Pages

IRF4 as an Oncogenic Master Transcription Factor

  • Regina Wan Ju Wong,
  • Jolynn Zu Lin Ong,
  • Madelaine Skolastika Theardy and
  • Takaomi Sanda

2 September 2022

IRF4 is a transcription factor in the interferon regulatory factor (IRF) family. Since the discovery of this gene, various research fields including immunology and oncology have highlighted the unique characteristics and the importance of IRF4 in sev...

(This article belongs to the Special Issue Phase Separation, Chromatin Organization and Transcription for Cancers)
  • Article
  • Open Access
2 Citations
2,906 Views
14 Pages

Exploratory Circular RNA Profiling in Adrenocortical Tumors

  • Péter István Turai,
  • Gábor Nyirő,
  • Katalin Borka,
  • Tamás Micsik and ,
  • István Likó,
  • Attila Patócs and
  • Peter Igaz
  • + 2 authors+ 0 author

2 September 2022

Differentiation of adrenocortical adenoma (ACA) and carcinoma (ACC) is often challenging even in the histological analysis. Circular RNAs (circRNAs) belonging to the group of non-coding RNAs have been implicated as relevant factors in tumorigenesis....

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
20 Citations
3,237 Views
15 Pages

The Therapeutic Role of Plastic and Reconstructive Surgery in the Interdisciplinary Treatment of Soft-Tissue Sarcomas in Germany—Cross-Sectional Results of a Prospective Nationwide Observational Study (PROSa)

  • Benjamin Thomas,
  • Amir K. Bigdeli,
  • Steffen Nolte,
  • Emre Gazyakan and ,
  • Leila Harhaus,
  • Oliver Bischel,
  • Burkhard Lehner,
  • Gerlinde Egerer,
  • Gunhild Mechtersheimer and
  • Ulrich Kneser
  • + 11 authors+ 6 authors

2 September 2022

Although the involvement of plastic surgery has been deemed important in the treatment of sarcoma patients to avoid oncological compromises and ameliorate patient outcomes, it is not ubiquitously available. The accessibility of defect reconstruction...

(This article belongs to the Special Issue Soft and Hard Tissue Sarcoma—Current and Future Concepts in Diagnosis and Treatment)
  • Article
  • Open Access
11 Citations
4,587 Views
17 Pages

Single-Cell Profiling of the Immune Atlas of Tumor-Infiltrating Lymphocytes in Endometrial Carcinoma

  • Fang Jiang,
  • Yuhao Jiao,
  • Kun Yang,
  • Mingyi Mao and ,
  • Mei Yu,
  • Dongyan Cao and
  • Yang Xiang
  • + 2 authors+ 0 author

2 September 2022

Endometrial carcinoma (EC) is a gynecological malignancy with a high incidence; however, thorough studies on tumor-infiltrating lymphocyte (TIL) populations in EC are lacking. We aimed to map the immune atlas of TILs in type I EC via single-cell RNA...

(This article belongs to the Collection Application of Bioinformatics in Cancers)
  • Article
  • Open Access
13 Citations
3,633 Views
17 Pages

Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming

  • Yuanzheng Yang,
  • Zhanglong Peng,
  • Elsa R. Flores and
  • Eugenie S. Kleinerman

2 September 2022

Despite aggressive combination chemotherapy and surgery, outcomes for patients with osteosarcoma have remained stagnant for more than 25 years, and numerous clinical trials have identified no new therapies. p53 deletion or mutation is found in more t...

(This article belongs to the Topic Targeting Tumor Metabolism for Cancer Therapy)
  • Article
  • Open Access
8 Citations
2,568 Views
11 Pages

Efficacy and Optimal Pressure of Continuous Positive Airway Pressure in Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer

  • Jaehyeon Park,
  • Ji Woon Yea,
  • Se An Oh,
  • Jongmoo Park and ,
  • Jae Won Park and
  • Jeong Eun Lee
  • + 1 author+ 0 author

2 September 2022

We aimed to determine the optimal pressure of continuous positive airway pressure (CPAP) for radiotherapy (RT) through changes in the dosimetric parameters and lung volume according to pressure. Patients with locally advanced lung cancer, who underwe...

  • Review
  • Open Access
12 Citations
3,517 Views
12 Pages

Application of C-Terminal Clostridium Perfringens Enterotoxin in Treatment of Brain Metastasis from Breast Cancer

  • Amita R. Banga,
  • Peace Odiase,
  • Kartik Rachakonda,
  • Amar P. Garg and ,
  • Samuel E. Adunyah and
  • Girish Rachakonda
  • + 1 author+ 0 author

2 September 2022

Claudin-4 is part of the Claudin family of transmembrane tight junction (TJ) proteins found in almost all tissues and, together with adherens junctions and desmosomes, forms epithelial and endothelial junctional complexes. Although the distribution o...

  • Article
  • Open Access
12 Citations
4,325 Views
16 Pages

A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy

  • Maria F. Iannó,
  • Veronica Biassoni,
  • Elisabetta Schiavello,
  • Andrea Carenzo and ,
  • Luna Boschetti,
  • Lorenza Gandola,
  • Barbara Diletto,
  • Edoardo Marchesi,
  • Claudia Vegetti and
  • Loris De Cecco
  • + 17 authors+ 12 authors

2 September 2022

Diffuse midline gliomas (DMGs) originate in the thalamus, brainstem, cerebellum and spine. This entity includes tumors that infiltrate the pons, called diffuse intrinsic pontine gliomas (DIPGs), with a rapid onset and devastating neurological symptom...

(This article belongs to the Special Issue Pediatric Brain Tumors)
  • Article
  • Open Access
15 Citations
3,482 Views
16 Pages

Exercise Promotes Pro-Apoptotic Ceramide Signaling in a Mouse Melanoma Model

  • Jonghae Lee,
  • Hannah Savage,
  • Shinji Maegawa,
  • Riccardo Ballarò and ,
  • Sumedha Pareek,
  • Bella Samia Guerrouahen,
  • Vidya Gopalakrishnan and
  • Keri Schadler
  • + 3 authors+ 0 author

2 September 2022

Ceramides are essential sphingolipids that mediate cell death and survival. Low ceramide content in melanoma is one mechanism of drug resistance. Thus, increasing the ceramide content in tumor cells is likely to increase their sensitivity to cytotoxi...

(This article belongs to the Special Issue Epidemiology and Biological Features of Melanoma)
  • Review
  • Open Access
25 Citations
10,043 Views
23 Pages

Bone Health Management in the Continuum of Prostate Cancer Disease

  • Ettickan Boopathi,
  • Ruth Birbe,
  • Sunday A. Shoyele,
  • Robert B. Den and
  • Chellappagounder Thangavel

2 September 2022

Prostate cancer (PCa) is the second-leading cause of cancer-related deaths in men. PCa cells require androgen receptor (AR) signaling for their growth and survival. Androgen deprivation therapy (ADT) is the preferred treatment for patients with local...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
21 Citations
3,516 Views
34 Pages

Novel Selenoesters as a Potential Tool in Triple-Negative Breast Cancer Treatment

  • Dominika Radomska,
  • Robert Czarnomysy,
  • Anna Szymanowska,
  • Dominik Radomski and ,
  • Enrique Domínguez-Álvarez,
  • Anna Bielawska and
  • Krzysztof Bielawski
  • + 2 authors+ 0 author

2 September 2022

Disturbing cancer statistics, especially for breast cancer, are becoming a rationale for the development of new anticancer therapies. For the past several years, studies have been proving a greater role of selenium in the chemoprevention of many canc...

(This article belongs to the Special Issue Triple Negative Breast Cancer: From Biology to Treatment)
  • Review
  • Open Access
7 Citations
3,458 Views
14 Pages

2 September 2022

Malignant pleural mesothelioma (MPM) is a rare, incurable cancer of the mesothelial cells lining the lungs and the chest wall that is mainly caused by asbestos inhalation. The molecular mechanisms of mesothelial carcinogenesis are still unclear despi...

(This article belongs to the Special Issue Molecular Mechanisms of Lung Cancer and Mesothelioma)
  • Article
  • Open Access
13 Citations
3,468 Views
15 Pages

Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients

  • Chumut Phanthunane,
  • Rebecca Wijers,
  • Maria J. De Herdt,
  • Senada Koljenović and ,
  • Stefan Sleijfer,
  • Robert J. Baatenburg de Jong,
  • José Angelito U. Hardillo,
  • Reno Debets and
  • Hayri E. Balcioglu
  • + 4 authors+ 0 author

1 September 2022

In early oral squamous cell carcinoma (OSCC), the occurrence of clusters between CD20 B cells and CD4 T cells in the invasive margin (IM) can be captured by using the CD20 cluster score, and is positively associated with patient survival. However, th...

(This article belongs to the Special Issue Immune Microenvironment and Cancer Progression)
  • Review
  • Open Access
15 Citations
5,461 Views
17 Pages

Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic

  • Jennifer K. Matsui,
  • Haley K. Perlow,
  • Cyril Baiyee,
  • Alex R. Ritter and ,
  • Mark V. Mishra,
  • Joseph A. Bovi,
  • Vinai Gondi,
  • Paul D. Brown,
  • Ashlee R. Loughan and
  • Joshua D. Palmer
  • + 7 authors+ 2 authors

1 September 2022

Brain metastases (BMs) account for a disproportionately high percentage of cancer morbidity and mortality. Historically, studies have focused on improving survival outcomes, and recent radiation oncology clinical trials have incorporated HRQOL and co...

(This article belongs to the Special Issue Diagnosis and Treatment of Brain Metastases)
  • Systematic Review
  • Open Access
24 Citations
3,574 Views
13 Pages

Surgical Outcomes of VRAM vs. Gracilis Flaps in Vulvo-Perineal Reconstruction Following Oncologic Resection: A Proportional Meta-Analysis

  • Ebai A. Eseme,
  • Matteo Scampa,
  • Juan A. Viscardi,
  • Myriam Ebai and ,
  • Daniel F. Kalbermatten and
  • Carlo M. Oranges
  • + 1 author+ 0 author

1 September 2022

Pelvic exenteration and abdominoperineal resection are radical techniques commonly used for locally advanced or recurrent pelvic malignancy with high morbidity due to large pelvic defects. Flaps can help provide healthy, well-vascularized, non-irradi...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
33 Citations
8,431 Views
15 Pages

1 September 2022

Ovarian cancer (OC) is the most lethal gynecological malignancy, with about 70% of cases diagnosed only at an advanced stage. Cannabis sativa, which produces more than 150 phytocannabinoids, is used worldwide to alleviate numerous symptoms associated...

(This article belongs to the Collection Stemness and Drug-Persistence in Cancer)
  • Article
  • Open Access
11 Citations
4,702 Views
15 Pages

Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL

  • Mahdi Nohtani,
  • Katerina Vrzalikova,
  • Maha Ibrahim,
  • Judith E. Powell and ,
  • Éanna Fennell,
  • Susan Morgan,
  • Richard Grundy,
  • Keith McCarthy,
  • Sarah Dewberry and
  • Paul G. Murray
  • + 8 authors+ 3 authors

1 September 2022

In this study, we have re-evaluated how EBV status influences clinical outcome. To accomplish this, we performed a literature review of all studies that have reported the effect of EBV status on patient outcome and also explored the effect of EBV pos...

(This article belongs to the Special Issue Epstein-Barr Virus Infection in Cancer)
  • Review
  • Open Access
31 Citations
6,361 Views
19 Pages

The Immune Landscape of Papillary Thyroid Cancer in the Context of Autoimmune Thyroiditis

  • Fabiana Pani,
  • Paola Caria,
  • Yoshinori Yasuda,
  • Miyara Makoto and ,
  • Stefano Mariotti,
  • Laurence Leenhardt,
  • Solmaz Roshanmehr,
  • Patrizio Caturegli and
  • Camille Buffet
  • + 4 authors+ 0 author

1 September 2022

Papillary thyroid cancer (PTC) often co-occurs with Hashimoto’s thyroiditis, an association that has long been reported in clinical studies, remaining controversial. Experimental evidence has recently shown that pre-existing thyroiditis has a b...

(This article belongs to the Special Issue Advances in Understanding the Immune Network of Thyroid Cancers)
  • Review
  • Open Access
26 Citations
4,632 Views
14 Pages

Therapeutic Potential for Targeting Autophagy in ER+ Breast Cancer

  • Ryan M. Finnegan,
  • Ahmed M. Elshazly,
  • Patricia V. Schoenlein and
  • David A. Gewirtz

1 September 2022

While endocrine therapy remains the mainstay of treatment for ER-positive, HER2-negative breast cancer, tumor progression and disease recurrence limit the utility of current standards of care. While existing therapies may allow for a prolonged progre...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
4 Citations
3,155 Views
15 Pages

1 September 2022

Background: Cancer is one of the leading causes of death among Polish women in general, and first in women aged 25–64. Contributing to this cancer burden are modifiable behavioral risk factors, including low utilization of cancer screenings. Po...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Review
  • Open Access
22 Citations
5,733 Views
12 Pages

The Role of Programmed Necrosis in Colorectal Cancer

  • Yu-Qiang Yu,
  • Reyes Gamez-Belmonte,
  • Jay V. Patankar,
  • Eva Liebing and
  • Christoph Becker

1 September 2022

For quite a long time, necrosis was considered a chaotic and unorganized form of cell death. However, studies conducted during the past few decades unveiled multiple types of programmed necrosis, such as necroptosis, pyroptosis and ferroptosis. These...

(This article belongs to the Collection New Treatment for Colorectal Cancer)

of 6

XFacebookLinkedIn
Cancers - ISSN 2072-6694